Chairman of TauRx and Dr Emer MacSweeney of Re:Cognition Health to speak at ADI Middle East Conference in Dubai on 8-9 December
Two innovative UK thought leaders in Alzheimer’s disease will be speaking at the upcoming 2nd Middle East and North Africa Conference of Alzheimer's Disease International this weekend.
In Croatia, three international leaders in Alzheimer’s discuss ongoing clinical trials and global dementia policy ahead of the G8 Dementia Research Summit in London next week
Professor Claude Wischik, Chairman of TauRx Therapeutics, Marc Wortmann, Executive Director of Alzheimer’s Disease International (ADI), and Prof. Ninoslav Mimica, President of Alzheimer Croatia, provide the latest news about ADI’s global dementia policy and the Croatian launch of a global Alzheimer’s Research Study
Professor Wischik speaks at annual psychogeriatric conference in Korea
Over 300 patients now enrolled worldwide in clinical trials for a second‐generation tau aggregation inhibitor (TAI) aimed at halting the progression of Alzheimer’s
In Toronto, Two International Leaders Share One Goal: Slow or Halt the Progression of Alzheimer’s Disease with the Launch of Phase 3 Clinical Trials
Professor Claude Wischik, Executive Chairman of TauRx Therapeutics and Dr. Sharon Cohen, Medical Director of the Toronto Memory Program Announce the Canadian Launch of Pivotal Alzheimer’s Research
Clinical trials get under way in the UK with a second‐generation tau aggregation inhibitor (TAI) aimed at halting the progression of Alzheimer’s
Demographic and societal impact of Alzheimer’s in China will grow exponentially if its current course is not averted, according to pioneer in tau pathology, a hallmark of Alzheimer’s Disease A new treatment targeting tau pathology is tomorrow’s hope for a brighter future, and Phase 3 clinical studies are bringing us closer to that goal.
Dundee Corporation maintains 5% stake in company developing a revolutionary treatment for Alzheimer’s Disease.
Major Conference in Poland will Spotlight TauRx Therapeutics as an Example of International Entrepreneurial Success in Life Science